ASXL1 Mutations Associated with Cytogenetic Findings in DE NOVO and Secondary Acute Myeloid Leukemia

被引：0
|
作者：
Kakosaiou, K. [1 ]
Daraki, A. [1 ]
Apostolou, P. [2 ]
Zachaki, S. [1 ]
Pagoni, M. [3 ]
Sambani, C. [1 ]
Dimitriadis, G. [4 ]
Papa, V. [4 ]
Manola, K. N. [1 ]
机构：
[1] Natl Ctr Sci Res Demokritos, Lab Hlth Phys Radiobiol & Cytogenet, Athens, Greece
[2] Natl Ctr Sci Res Demokritos, Mol Diagnost Lab, Athens, Greece
[3] Evangelismos Med Ctr, Dept Hematol & Lymphoma, Athens, Greece
[4] Univ Gen Hosp Attikon, Med Sch Athens, Hematol Unit, Athens, Greece
来源：
ANNALS OF HEMATOLOGY | 2015年 / 94卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
20
引用
收藏
页码：S80 / S80
页数：1
相关论文
共 50 条
  • [41] DISTINCT CLINICAL AND BIOLOGICAL CHARACTERISTICS OF ADULT PATIENTS WITH DE NOVO ACUTE MYELOID LEUKEMIA WITH ADDITIONAL SEX COMB-LIKE 1 (ASXL1) MUTATION
    Huang, H. H.
    Chou, W. C.
    Hou, H. A.
    Chen, C. Y.
    Tien, H. F.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 14 - 15
  • [42] DIAGNOSIS AND MANAGEMENT OF BOHRING-OPITZ SYNDROME CAUSED BY DE NOVO ASXL1 MUTATIONS
    Russell, B.
    Nasiak, M.
    Kramer, N.
    Johnston, J.
    Biesecker, L.
    Graham, J. M.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2013, 61 (01) : 165 - 165
  • [43] Analysis of ASXL1, IDH1, IDH2, c-CBL, and WT1 Mutations in De Novo Acute Myeloid Leukaemia
    Ibanez, Mariam
    Such, Esperanza
    Cervera, Jose
    Luna, Irene
    Dolz, Sandra
    Gomez-Segui, Ines
    Lopez-Pavia, Maria
    Costan, Beatriz
    Barragan, Eva
    Fuster, Oscar
    Llop, Marta
    Oltra, Silvestre
    Moscardo, Federico
    Montesinos, Pau
    Martinez-Cuadron, David
    Sanz, Miguel A.
    BLOOD, 2011, 118 (21) : 630 - 630
  • [44] Analysis of ASXL1 Mutations in a Large Series of Myeloid Malignancies
    Van Ness, Michael
    Szankasi, Philippe
    Frizzell, Kimberly
    Shen, Wei
    Kelley, Todd W.
    LABORATORY INVESTIGATION, 2016, 96 : 381A - 381A
  • [45] Analysis of ASXL1 Mutations in a Large Series of Myeloid Malignancies
    Van Ness, Michael
    Szankasi, Philippe
    Frizzell, Kimberly
    Shen, Wei
    Kelley, Todd W.
    MODERN PATHOLOGY, 2016, 29 : 381A - 381A
  • [46] ASXL1 mutations are frequent in de novo AML with trisomy 8 and confer an unfavorable prognosis
    Zong, Xiangping
    Yao, Hong
    Wen, Lijun
    Ma, Liang
    Wang, Qinrong
    Yang, Zhiluo
    Zhang, Tongtong
    Chen, Suning
    Wu Depei
    LEUKEMIA & LYMPHOMA, 2017, 58 (01) : 204 - 206
  • [47] Mutations in ASXL1 are associated with poor prognosis across the spectrum of malignant myeloid diseases
    Véronique Gelsi-Boyer
    Mandy Brecqueville
    Raynier Devillier
    Anne Murati
    Marie-Joelle Mozziconacci
    Daniel Birnbaum
    Journal of Hematology & Oncology, 5
  • [48] Mutual exclusion of ASXL1 and NPM1 mutations in a series of acute myeloid leukemias
    N Carbuccia
    V Trouplin
    V Gelsi-Boyer
    A Murati
    J Rocquain
    J Adélaïde
    S Olschwang
    L Xerri
    N Vey
    M Chaffanet
    D Birnbaum
    M J Mozziconacci
    Leukemia, 2010, 24 : 469 - 473
  • [49] Mutations in ASXL1 are associated with poor prognosis across the spectrum of malignant myeloid diseases
    Gelsi-Boyer, Veronique
    Brecqueville, Mandy
    Devillier, Raynier
    Murati, Anne
    Mozziconacci, Marie-Joelle
    Birnbaum, Daniel
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2012, 5
  • [50] ASXL1 mutations predict inferior molecular response to nilotinib treatment in chronic myeloid leukemia
    Lioba Schönfeld
    Jenny Rinke
    Anna Hinze
    Saskia N. Nagel
    Vivien Schäfer
    Thomas Schenk
    Christian Fabisch
    Tim H. Brümmendorf
    Andreas Burchert
    Philipp le Coutre
    Stefan W. Krause
    Susanne Saussele
    Fatemeh Safizadeh
    Markus Pfirrmann
    Andreas Hochhaus
    Thomas Ernst
    Leukemia, 2022, 36 : 2242 - 2249
12345